Compound Detail
CHEMBL1236821
XYLOSE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1236821 |
| Name | XYLOSE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PYMYPHUHKUWMLA-VPENINKCSA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
14
Publications
4
Known Names
Molecular Properties
150.1
MW (Da)
-2.74
ALogP
5
HBA
4
HBD
98.0
PSA (Ų)
0.33
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Discontinued |
| Chirality | Single Enantiomer |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19049348 | 10.1021/jm8008713 | L6 | 13 |
| 19049348 | 10.1021/jm8008713 | Unchecked | 5 |
| 10397501 | 10.1016/s0960-894x(99)00255-3 | Aldo-keto reductase family 1 member B1 | 3 |
| 19135365 | 10.1016/j.bmcl.2008.12.037 | NHDF | 3 |
| 26832785 | 10.1016/j.bmcl.2016.01.063 | NCI-H1299 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 7031247 | 10.1021/jm00143a005 | Acrosin | 1 |
| 17057723 | 10.1038/nchembio828 | Alpha 1,4 galactosyltransferase | 1 |
| 20020916 | 10.1080/15376510701857262 | Phospholipidosis | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| 26791015 | 10.1016/j.bmcl.2016.01.007 | Caenorhabditis elegans | 1 |
Data from ChEMBL 36 via Core Engine